Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yixin prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, in collaboration with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated to treat heart failure with preserved ejection fraction (HFpEF) in patients diagnosed with the TCM syndrome of qi deficiency and blood stasis. The prescription aims to improve cardiac function, alleviate clinical symptoms, and enhance the quality of life by tonifying qi and promoting blood circulation. It is currently undergoing clinical evaluation to assess its efficacy and safety in this specific patient population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yixin prescription.